Report copyright - Renu Lal FDA CDER SBIR'17 · Clinical Studies Phase I ‐First human subject studies ‐Determine pharmacologic and metabolic activity, safety and maximum tolerated dosage in humans,
Please pass captcha verification before submit form
Please pass captcha verification before submit form